FDA DEVICE FACTS
KINETIS Total Knee System
Mako Surgical
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The KINETIS™ Total Knee System components are indicated for use in skeletally mature patients, with severe knee pain and disability, undergoing primary surgery for total knee replacement due to: /g120 Rheumatoid arthritis, osteoarthritic, traumatic arthritis, polyarthritis. /g120 Collagen disorders, and/or avascular necrosis of the femoral condyle /g120 Non-inflammatory degenerative joint disease including osteoarthritis, traumatic arthritis, or avascular necrosis /g120 Moderate valgus, varus, or flexion deformities. MAKO KINETIS™ Total Knee Replacement System components are indicated for use only with cement and are single use devices
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。